Skip to main content
OpenTrials
Completed

NCT Number: NCT02379325

Text Message Stop Smoking Among Young Population

Smoking cessation is a priority for preventing smoking-attributable disease and reducing its burden. Quitting smoking at any age confers substantial and immediate health benefits, including reduced risks of stroke, cardiovascular disease and smoking-related cancers, and quitting smoking by the age of 30 reduces the risk of dying from tobacco-related diseases by almost 90%. The World Bank suggests that if adult cigarette consumption were to decrease by half in the year 2020, approximately 180 million tobacco-attributable deaths could be avoided. Therefore, promotion of smoking cessation has been proposed as a primary focus of tobacco control efforts, especially in developing countries where smoking prevalence and cigarette consumption are both still relatively high

Completed

Looking for future studies?

Notify Me

Key information

Age range

20 year–25 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

About this study

most risk factors are associated with more than one disease, and targeting those factors can reduce multiple causes of disease. Since smoking has 9% contributions on the leading global risk towards mortality in the world and this risk factor has resulted in multiple causes of disease for example, lung cancer, heart disease, stroke, chronic respiratory disease and other conditions therefore by quantifying the impact of this risk factors on diseases, may help to decrease the number of burden disease that is caused by smoking. University students age of 18 -24 are among the group of age that has the highest prevalence on smoking, thus it is necessary to targeting the high-risk people, who are most likely to benefit from the intervention. Population-based strategies seek to change the social norm by encouraging an increase in healthy behavior and a reduction in health risk. University students are in transition between the adolescence and early adulthood and developed unhealthy behaviors like cigarette smoking

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Smokers aged 18 - 24 years old
  • Owned a mobile phone with text messaging capabilities
  • Intention to quit
  • No current use of nicotine replacement treatment or bupropion in the past month
  • Not in treatment for any substance abuse disorder within the past year

Exclusion criteria

  • Not a smoker
  • No desire to quit smoking-
  • Who unwillingly to participate in this study

Treatment and study plan

Lets Quit

Behavioral

Five tracks were created including "Not Ready", "Beginner", "Advance", "Relapse", and "Distraction". The "Distraction" track was combined with all of the other remaining 4 tracks. It was aimed as a distraction (as the name indicated) method to lighten the participants mood. It consisted of general information such as sports, fashion, dining, movies, and travelling.

Pamphlets material

Behavioral

Given pamphlets material on smoking and complication

Primary outcomes

  1. Quit rates

    Time frame: 2 months

  2. Time-line follow-back (TLFB)

    Time frame: 2 months

  3. The Fagerstrom Test for Nicotine Dependence

    Time frame: 2 months

  4. CO level

    Time frame: 2 months

Sponsors and collaborators

Lead sponsor

Universiti Kebangsaan Malaysia Medical Centre

Other

Registry information

Official study title

4-Weeks Intervention of Mobile Phone Text Messaging (Let's Quit!) on Smoking Cessation Among University Students: A Non Randomized Controlled Trial

Important dates

Study start
2014
Primary completion
2014
Study completion
2014
First posted
Mar 4, 2015
Registry last updated
Mar 4, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.